UPDATE : Wednesday, August 5, 2020
Bio & Medical Korea 2018 opens May 9
Acting President Hwang Kyo-an (center) and other dignitaries cut ribbons to...
by Lee Han-soo  |  2018-05-08 17:59
Spectra to market Huons’ local anesthetics in US
Huons said Monday that it has signed an agreement with Spectra Medical, Huo...
by Lee Han-soo  |  2018-05-08 16:35
Boryung’s antihypertensive drug Kanarb tops output among new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb ranked No. 1 in ...
by So Jae-hyeon  |  2018-05-08 16:05
Daewoong to seek US nod for liver drug Ursa this year
Daewoong Pharmaceutical said its liver drug Ursa was likely to become the c...
by So Jae-hyeon  |  2018-05-08 14:37
Does Celltrion’s biosimilar have price edge over Roche’s Herceptin?
Competition has been intensifying in the breast cancer therapy market due t...
by Marian Chu  |  2018-05-04 18:15
Janssen Korea gets prostate cancer drug reimbursed as 2nd line therapy
ZYTIGA Janssen Korea said that its prostate cancer therapy ZYTIGA (ingred...
by Marian Chu  |  2018-05-04 17:01
Daewoong compares Nabota with Botox in US, Mexico
Daewoong Pharmaceutical is actively promoting Nabota, an injectable type A ...
by Lee Hye-seon  |  2018-05-04 14:27
AstraZeneca Korea’s antiplatelet therapy gets insurance coverage
AstraZeneca Korea said Thursday that a 60 mg dose of its oral antiplatelet ...
by Marian Chu  |  2018-05-04 11:56
Hanmi posts ₩245.7 billion in Q1 sales
Hanmi Pharmaceutical said Thursday that it recorded 245.7 billion won ($228...
by Lee Han-soo  |  2018-05-03 14:52
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun  |  2018-05-03 14:51
SK Chemicals approves spinoff of its vaccine biz
SK Chemicals said Thursday that the company’s board of directors has approv...
by Lee Han-soo  |  2018-05-03 14:33
Abbvie applies for European marketing approval for investigational psoriasis therapy
Illinois-based pharmaceutical firm Abbvie has submitted a marketing authori...
by Marian Chu  |  2018-05-03 13:12
Roche gets expanded reimbursement for ovarian cancer therapy
Roche Korea (CEO: Matt Sause) said that its targeted therapy Avastin (ingre...
by Marian Chu  |  2018-05-02 18:17
Lilly Korea’s gastric cancer drug gets expanded reimbursement
The Korean branch of Eli Lilly and Company said that its gastric cancer the...
by Marian Chu  |  2018-05-02 17:13
JW Pharma, Syntekabio agree to develop new drugs using AI
JW Pharmaceutical said Wednesday that it has signed a memorandum of underst...
by Lee Han-soo  |  2018-05-02 16:33
Gtree presents dry eye treatment at US conference
Gtree BNT said Wednesday that it has presented data regarding RGN-259, a dr...
by Lee Han-soo  |  2018-05-02 15:37
Bayer’s liver cancer drug gets more reimbursement as 2nd line therapy
Bayer Korea’s targeted liver cancer therapy Stivarga (ingredient: regorafen...
by Marian Chu  |  2018-05-02 15:36
Genexine, Roche to research combination treatment for cancer
Genexine and its U.S. subsidiary NeoImmuneTech said Wednesday they have sig...
by Lee Han-soo  |  2018-05-02 15:13
US court dismisses Medytox’s suit against Daewoong without prejudice
The war of nerves between Daewoong Pharmaceuticals and Medytox over the ori...
by Lee Han-soo  |  2018-04-30 17:31
Korean pharma firms target rare diseases to enter US market
Domestic pharmaceutical companies are targeting the U.S. market with rare d...
by So Jae-hyeon  |  2018-04-30 16:42
Back to Top